首页> 外文期刊>JACC. Cardiovascular interventions >Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism
【24h】

Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism

机译:经导管封闭与药物治疗卵圆孔未闭的Meta分析,以预防假定的悖论性栓塞后复发的神经系统事件

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: In this study, a meta-analysis of observational studies was performed to compare the rate of recurrent neurological events (RNE) between transcatheter closure and medical management of patients with cryptogenic stroke/transient ischemic attack (TIA) and concomitant patent foramen ovale (PFO). Background: A significant controversy surrounds the optimal strategy for treatment of cryptogenic stroke/TIA and coexistent PFO. Methods: We conducted a MEDLINE search with standard search terms to determine eligible studies. Results: Adjusted incidence rates of RNE were 0.8 (95% confidence interval [CI]: 0.5 to 1.1) events and 5.0 (95% CI: 3.6 to 6.9) events/100 person-years (PY) in the transcatheter closure and medical management arms, respectively. Meta-analysis of the limited number of comparative studies and meta-regression analysis suggested that the transcatheter closure might be superior to the medical therapy in prevention of RNE after cryptogenic stroke. Comparison of the anticoagulation and antiplatelet therapy subgroups of the medical arm yielded a significantly lower risk of RNE within patients treated with anticoagulants. Device-related complications were encountered at the rate of 4.1 (95% CI: 3.2 to 5.0) events/100 PY, with atrial arrhythmias being the most frequent complication. After transcatheter closure, RNE did not seem to be related to the pre-treatment shunt size or the presence of residual shunting in the follow-up period. Significant benefit of transcatheter PFO closure was apparent in elderly patients, patients with concomitant atrial septal aneurysm, and patients with thrombophilia. Conclusions: Rates of RNE with transcatheter closure and medical therapy in patients presenting with cryptogenic stroke or TIA were estimated at 0.8 and 5.0 events/100 PY. Further randomized controlled trials are needed to conclusively compare these 2 management strategies.
机译:目的:在这项研究中,进行了一项观察性研究的荟萃分析,比较了患有隐源性卒中/短暂性脑缺血发作(TIA)和伴发卵圆孔未闭的患者经导管闭合与药物治疗之间的复发性神经系统事件(RNE)发生率( PFO)。背景:关于治疗隐源性卒中/ TIA和共存PFO的最佳策略围绕着一个重大争议。方法:我们使用标准搜索词进行了MEDLINE搜索,以确定符合条件的研究。结果:经导管闭合和药物治疗后,RNE的调整发生率是0.8(95%置信区间[CI]:0.5至1.1)事件和5.0(95%CI:3.6至6.9)事件/ 100人年(PY)。武器,分别。对有限数量的比较研究和荟萃回归分析的荟萃分析表明,在隐源性卒中后,经导管封闭在预防RNE方面可能优于药物治疗。比较医疗组的抗凝和抗血小板治疗亚组可以显着降低接受抗凝剂治疗的患者的RNE风险。发生与设备相关的并发症的发生率为100 PY 4.1(95%CI:3.2至5.0)事件,房性心律失常是最常见的并发症。经导管闭合后,RNE似乎与治疗前分流的大小或随访期间是否存在残余分流无关。经导管PFO封堵对老年患者,伴发性房间隔动脉瘤和血栓形成性患者明显有益。结论:对于隐源性卒中或TIA患者,经导管封闭和药物治疗的RNE发生率估计为0.8和5.0事件/ 100 PY。需要进一步的随机对照试验来最终比较这两种管理策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号